收费全文 | 534篇 |
免费 | 41篇 |
国内免费 | 50篇 |
耳鼻咽喉 | 5篇 |
儿科学 | 16篇 |
妇产科学 | 6篇 |
基础医学 | 67篇 |
口腔科学 | 8篇 |
临床医学 | 64篇 |
内科学 | 91篇 |
皮肤病学 | 4篇 |
神经病学 | 28篇 |
特种医学 | 67篇 |
外科学 | 60篇 |
综合类 | 22篇 |
预防医学 | 40篇 |
眼科学 | 6篇 |
药学 | 76篇 |
中国医学 | 1篇 |
肿瘤学 | 64篇 |
2023年 | 3篇 |
2022年 | 3篇 |
2021年 | 12篇 |
2020年 | 10篇 |
2019年 | 10篇 |
2018年 | 18篇 |
2017年 | 14篇 |
2016年 | 5篇 |
2015年 | 21篇 |
2014年 | 10篇 |
2013年 | 17篇 |
2012年 | 23篇 |
2011年 | 14篇 |
2010年 | 15篇 |
2009年 | 11篇 |
2008年 | 19篇 |
2007年 | 45篇 |
2006年 | 23篇 |
2005年 | 20篇 |
2004年 | 14篇 |
2003年 | 14篇 |
2002年 | 17篇 |
2001年 | 15篇 |
2000年 | 16篇 |
1999年 | 16篇 |
1998年 | 9篇 |
1997年 | 11篇 |
1996年 | 17篇 |
1995年 | 10篇 |
1994年 | 9篇 |
1993年 | 20篇 |
1992年 | 9篇 |
1991年 | 13篇 |
1990年 | 20篇 |
1989年 | 17篇 |
1988年 | 13篇 |
1987年 | 12篇 |
1986年 | 9篇 |
1985年 | 4篇 |
1984年 | 4篇 |
1982年 | 7篇 |
1981年 | 4篇 |
1979年 | 3篇 |
1977年 | 4篇 |
1976年 | 7篇 |
1974年 | 4篇 |
1973年 | 3篇 |
1972年 | 4篇 |
1970年 | 7篇 |
1967年 | 3篇 |
Introduction
A stay in the intensive care unit (ICU), although potentially life-saving, may cause considerable discomfort to patients. However, retrospective assessment of discomfort is difficult because recollection of stressful events may be impaired by sedation and severe illness during the ICU stay. This study addresses the following questions. What is the incidence of discomfort reported by patients recently discharged from an ICU? What were the sources of discomfort reported? What was the degree of factual recollection during patients' stay in the ICU? Finally, was discomfort reported more often in patients with good factual recollection?Methods
All ICU patients older than 18 years who had needed prolonged (>24 hour) admission with tracheal intubation and mechanical ventilation were consecutively included. Within three days after discharge from the ICU, a structured, in-person interview was conducted with each individual patient. All patients were asked to complete a questionnaire consisting of 14 questions specifically concerning the environment of the ICU they had stayed in. Furthermore, they were asked whether they remembered any discomfort during their stay; if they did then they were asked to specify which sources of discomfort they could recall. A reference group of surgical ward patients, matched by sex and age to the ICU group, was studied to validate the questionnaire.Results
A total of 125 patients discharged from the ICU were included in this study. Data for 123 ICU patients and 48 surgical ward patients were analyzed. The prevalence of recollection of any type of discomfort in the ICU patients was 54% (n = 66). These 66 patients were asked to identify the sources of discomfort, and presence of an endotracheal tube, hallucinations and medical activities were identified as such sources. The median (min–max) score for factual recollection in the ICU patients was 15 (0–28). The median (min–max) score for factual recollection in the reference group was 25 (19–28). Analysis revealed that discomfort was positively related to factual recollection (odds ratio 1.1; P < 0.001), especially discomfort caused by the presence of an endotracheal tube, medical activities and noise. Hallucinations were reported more often with increasing age. Pain as a source of discomfort was predominantly reported by younger patients.Conclusion
Among postdischarge ICU patients, 54% recalled discomfort. However, memory was often impaired: the median factual recollection score of ICU patients was significantly lower than that of matched control patients. The presence of an endotracheal tube, hallucinations and medical activities were most frequently reported as sources of discomfort. Patients with a higher factual recollection score were at greater risk for remembering the stressful presence of an endotracheal tube, medical activities and noise. Younger patients were more likely to report pain as a source of discomfort.Areas covered: This review presents the current status of novel biological therapies used in the treatment of DFU. Literature information and data analysis were collected from PubMed, the website of the American Diabetes Association, and ClinicalTrials.gov. The keywords used in the search were: DM, DFU, complications of DM.
Expert opinion: Many biological agents have been investigated in a bid to find an effective therapy for DFU. These include growth factors (platelet-derived growth factor, vascular endothelial growth factor etc), stem cells (epithelial progenitor-, adipose-derived stem cells etc), anti-diabetic drugs (insulin, exendin-4), herbs, urokinase, dalteparin, statins and bio-agents such as acid peptide matrix. Biological agents that can reduce hyperglycaemia, increase sensation, microcirculation and oxygenation and repair lost tissue are the most ideal for the treatment of DFU. 相似文献
Areas covered: A systematic literature review was conducted on PubMed to identify evidence of the consequences of switching from original biologics to biosimilars. References of included papers were also scrutinized. After a title-, abstract- and full text screening, out of the 153 original hits and 77 additional ones from screening the references, 58 papers (12 empirical papers, 5 systematic reviews and 41 non-empirical papers) were included.
Expert opinion: Preventing patients on biologic medicines from switching to biosimilars due to anticipated risks seems to be disproportional compared to the expected cost savings and/or improved patient access. Indeed, it is the opinion of the authors that the concern of switching to biosimilars is overhyped. 相似文献